Evidence map›Paper›PMID 30849970›Full record

ArticleBMC biotechnology2019

Nicotiana benthamiana is a suitable transient system for high-level expression of an active inhibitor of cotton boll weevil α-amylase.

Guilherme Souza Prado, Pingdwende Kader Aziz Bamogo, Joel Antônio Cordeiro de Abreu, François-Xavier Gillet, Vanessa Olinto Dos Santos, Maria Cristina Mattar Silva, Jean-Paul Brizard, Marcelo Porto Bemquerer, Martine Bangratz, Christophe Brugidou and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Guilherme Souza PradoEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
Pingdwende Kader Aziz BamogoIRD, CIRAD, Université Montpellier, Interactions Plantes Microorganismes et Environnement (IPME), Montpellier, France.
Joel Antônio Cordeiro de AbreuEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
François-Xavier GilletEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
Vanessa Olinto Dos SantosEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
Maria Cristina Mattar SilvaEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
Jean-Paul BrizardIRD, CIRAD, Université Montpellier, Interactions Plantes Microorganismes et Environnement (IPME), Montpellier, France.
Marcelo Porto BemquererEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
Martine BangratzIRD, CIRAD, Université Montpellier, Interactions Plantes Microorganismes et Environnement (IPME), Montpellier, France.
Christophe BrugidouIRD, CIRAD, Université Montpellier, Interactions Plantes Microorganismes et Environnement (IPME), Montpellier, France.
Drissa SéréméINERA/LMI Patho-Bios, Institut de L'Environnement et de Recherches Agricoles (INERA), Laboratoire de Virologie et de Biotechnologies Végétales, Ouagadougou, Burkina Faso.
Maria Fatima Grossi-de-SaEmbrapa Genetic Resources and Biotechnology, Brasília, DF, Brazil.
Séverine LacombeIRD, CIRAD, Université Montpellier, Interactions Plantes Microorganismes et Environnement (IPME), Montpellier, France. severine.lacombe@ird.fr.
Brazilian Agricultural Research Corporation · BRCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRDiversité, génomes et interactions micro-organismes-insectes · FRInstitut de l'Environnement et Recherches Agricoles · BFInstitut de Recherche pour le Développement · FRUniversidade Católica de Brasília · BRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsect resistance in crops represents a main challenge for agriculture. Transgenic approaches based on proteins displaying insect resistance properties are widely used as efficient breeding strategies. To extend the spectrum of targeted pathogens and overtake the development of resistance, molecular evolution strategies have been used on genes encoding these proteins to generate thousands of variants with new or improved functions. The cotton boll weevil (Anthonomus grandis) is one of the major pests of cotton in the Americas. An α-amylase inhibitor (α-AIC3) variant previously developed via molecular evolution strategy showed inhibitory activity against A. grandis α-amylase (AGA).

resultsWe produced in a few days considerable amounts of α-AIC3 using an optimised transient heterologous expression system in Nicotiana benthamiana. This high α-AIC3 accumulation allowed its structural and functional characterizations. We demonstrated via MALDI-TOF MS/MS technique that the protein was processed as expected. It could inhibit up to 100% of AGA biological activity whereas it did not act on α-amylase of two non-pathogenic insects. These data confirmed that N. benthamiana is a suitable and simple system for high-level production of biologically active α-AIC3. Based on other benefits such as economic, health and environmental that need to be considerate, our data suggested that α-AIC3 could be a very promising candidate for the production of transgenic crops resistant to cotton boll weevil without lethal effect on at least two non-pathogenic insects.

conclusionsWe propose this expression system can be complementary to molecular evolution strategies to identify the most promising variants before starting long-lasting stable transgenic programs.

Indexed as

Gene Expressionalpha-AmylasesAnimalsDirected Molecular EvolutionEnzyme InhibitorsGene SilencingGenetic EngineeringInsect ControlNicotianaPlant ProteinsPlants, Genetically ModifiedWeevilsalpha-AmylasesEnzyme InhibitorsPlant ProteinsCotton boll weevilGene silencing suppressorsTransient protein expressionα-amylase inhibitors

Identifiers

PMID30849970
PMCPMC6408794
OpenAlexW2921970076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.